This article reports that despite the doubts about education financing, Israel's innovative companies spun off by universities show no signs of slowing down, as new drugs and other discoveries have produced huge incomes. Thirty years ago, two researchers at Hebrew University set about to make a better tomato. One that was firmer, stayed fresher longer, and could be harvested more easily. Haim D. Rabinowitch and his doctoral supervisor, Nachum Kedar, genetically engineered such a seed in 1973, setting off a worldwide revolution in tomato cultivation. It also made their university a lot of money. The technology-transfer arm of Hebrew University, known as Yissum, earned $51-million last year in royalties, partly from the seeds it licenses to two Israeli companies. Those companies, Hazera and Zeraim Gedera, which were eventually sold to Vilmorin and Syngenta, also employ many graduates of the university's agricultural school. The tomato-seed revolution, which has helped bring Hebrew University about $1-billion, is not even Yissum's biggest moneymaker these days. Drugs for Alzheimer's disease and cancer also bring in millions.